Notice to the media - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will be in Montréal all day Monday, December 11th
MONTREAL, Dec. 8, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will be in Montréal all day Monday December 11th.
In Montréal, she will meet, among others, the Mayor of Montréal, Valérie Plante. She will also participate in a roundtable with parents and youth on cannabis prevention at Maison Jean Lapointe, will be visiting the CHU Sainte-Justine, and will make an announcement on research related to opioids at the University of Montreal Hospital Research Centre (CRCHUM).
Media are invited to a press event at the CRCHUM.
Date December 11, 2017
Time 3:15 PM
Location Agora, 5th Floor, Pavillion R University of Montréal Hospital Research Centre (CRCHUM) 900, Saint-Denis Street Montréal, Québec
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering.
Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...